1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | It is alleged that residents’ medication goes missing daily with no explanation. On 07/07/26 LPA conducted interviews with R1-R10 regarding the allegation above. 7 of the 10 residents denied the allegation above and reported having no concerns with the staff who handle their medication(s). Additionally, 6 or 10 resident reported that they have never been told that their medication are unavailable. 1 of the 10 residents interviewed reported that there medications have been unavailable but reports it was due to pharmacy availability. 3 of the 10 residents interviewed reported being unaware if they take medications while currently receiving care at the facility. On 07/07/26 LPA conducted interviews with
On 07/07/26 from 10:00am- 11:31am LPA conducted a records review of the June 2026 and July 2026 medications administration records (MARs) for R1-R7. During the records review LPA observed that for July 2026 there were 16 medication documentation errors that affected 4 residents. The review showed missing initials for medications assigned to R1- Famotidine 20mg 8am- documented as refused but still in the pack for July 4th, 2026 Famotidine 20mg 4pm- documented as refused but are not in the bubble pack for July 1st-3rd 2026, Fluoxetine HCL 20mg- July 3rd, 2026 and July 7th, 2026 documented as refused but not in the bubble pack, July 6th, 2026 documented as given, then documented in the back that resident refused.
LPA observed the following for R2, Carbamazepine 8am am- July 2nd, 2026 documented given but in the bubble pack, Levetiracetam 8am July 2nd 2026 documented given but in the bubble pack, Tamsulosin 8am July 2nd, 2026 documented given but in the bubble pack. LPA observed the following for R4, Amitriptyline HCL 100mg 8 pm July 1st, 2026 documented as given but in the bubble pack, Atorvastatin 40 mg 8pm July 1st, 2026 documented as given but in the bubble pack Senna 8.6 mg 8pm July 1st, 2026 documented as given but in the bubble pack. LPA observed the following for R5 Besylate 2.5 mg 8am July 2nd, 2026 documented given but in the bubble pack, Benztropine MES 1pm 8am July 2nd, 2026 documented given but in the bubble pack, Benztropine MES 1pm 4 pm July 2nd, 2026 not signed out and not in the bubble pack, Divalproex DOS 500 mg 10pm out of bubble pack on 07/1/26, 07/3/26, 07/4/26 and on 07/5/26 but not signed out, Folic Acid 1mg 8am July 2nd, 2026 not documentation but inside bubble pack, Metformin 1000 mg 8am July 2nd, 2026 signed out but in the bubble pack, Metformin 1000 mg 4 pm July 2nd, 2026 not signed out and not in the bubble pack.
Based on LPAs observations and interviews which were conducted record review(s), the preponderance of evidence standard has been met, therefore the above allegation(s) is found to be substantiated. California Code of Regulations, Title 22, Division (6) and Chapter (8) are being cited on the attached LIC 9099D.
Exit interview provided, appeal rights explained, and a copy of this report was provided. |